RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases. The company also offers its discovery platforms and antiviral services to other biotechnology companies.
RetroVirox staff has decades of experience in the discovery and preclinical development of antiviral agents against HIV, HCV, influenza and other human pathogens. The Company specializes in offering antiviral assays and early stage discovery solutions to other Life Sciences companies working in the antiviral field. RetroVirox provides different opportunities to fulfill the needs of these companies, offering a menu of antiviral assays in a fee-for-service modality, and also as opportunities to establish collaborative efforts (Read more).
The Company’s internal R&D efforts are focused on solutions for some of the most challenging human pathogens: HIV, HCV, and other serious infections. RetroVirox was founded with an initial investment by scientists and entrepreneurs to translate into cures research previously funded by the National Institutes of Health (NIH).
RetroVirox is headquartered in San Diego, California
